• 1. Department of Evidence-based Medicine and Clinical Epidemiology, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 2. Division of Internal Medicine, Institute of Integrated Traditional Chinese and Western Medicine, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
  • 3. Center of Biostatistics, Design, Measurement and Evaluation (CBDME), Department of Clinical Research Management, West China Hospital, Sichuan University, Chengdu 610041, P. R. China;
KANG Deying, Email: deyingkang@126.com; ZHANG Xin, Email: zhangxinwch@126.com
Export PDF Favorites Scan Get Citation

Objective To explore the association between frailty and in-hospital mortality in older patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD). Methods  Elderly patients who were hospitalized with AECOPD from June 2022 to December 2022 at a large tertiary hospital were selected. The independent prognostic factors including frailty status were determined by multivariate logistic regression analysis. Mediation effect analysis was used to evaluate the mediating relationships between C-reactive protein (CRP) and albumin and in-hospital death. Results The training set included 1 356 patients (aged 86.7±6.6), 25.0% of whom were diagnosed with frailty. The multiple logistic regression analysis showed that frailty, mean arterial pressure, Charlson comorbidity index, neutrophil–lymphocyte ratio, interleukin-6, CRP, albumin, and troponin T were associated with in-hospital mortality. Furthermore, CRP and albumin mediated the associations between frailty and in-hospital mortality. Conclusion Frailty may be an adverse prognostic factor for older patients admitted with an AECOPD. CRP and albumin may be parts of mechanism between frailty and in-hospital death.

Citation: LI Li, WANG Lei, ZHANG Li, ZHAO Chongyang, WANG Qin, LIU Ying, LIU Lei, YUAN Lishan, FENG Min, WANG Gang, KANG Deying, ZHANG Xin. Frailty increases the risk of in-hospital mortality in older patients with acute exacerbation of chronic obstructive pulmonary disease: a real-world study. Chinese Journal of Evidence-Based Medicine, 2024, 24(6): 652-657. doi: 10.7507/1672-2531.202403072 Copy

  • Previous Article

    Clinical practice guideline for prevention and treatment of postoperative gastrointestinal disorder with integrated traditional Chinese and Western medicine (2023 edition)
  • Next Article

    Trends in migraine incidence and age-period-cohort analysis in China from 1990 to 2019